Login to Your Account

FDA Tackles Nanotechnology Impact on Drug Regulation

By Marie Powers
Staff Writer

Thursday, August 9, 2012
While the rest of the biotech world seems to embrace the arrival of nanotechnology in drug development, the FDA is still seeking to understand the nuances of products that contain nanoscale materials.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription